Classical swine fever virus (CSFV) is a noncytopathogenic (ncp) positive-sense RNA virus that replicates in myeloid cells including macrophages and dendritic cells (DC). The virus does not induce type I interferon (IFN-a/h), which in macrophages has been related to the presence of the viral N pro gene. In the present work, the role of viral double-stranded (ds)RNA and N pro in the virus -host cell interaction has been analyzed. Higher levels of detectable dsRNA were produced by a genetically engineered cytopathogenic (cp) CSFV compared with ncp CSFV, and cp CSFV induced IFN-a/h in PK-15 cells. With DC, there was only a small difference in the levels of dsRNA between the cp and ncp viruses, and no IFN-a/h was produced. However, the cp virus induced a higher degree of DC maturation, in terms of CD80/86 and MHC II expression. N pro deletion mutants induced an increase in DC maturation and IFN-a/h production -for both ncp and cp viruses -despite reduced replication efficiency in the DC. Deletion of N pro did not influence dsRNA levels, indicating that the interference was downstream of dsRNA turnover regulation. In conclusion, the capacity of CSFV to replicate in myeloid DC, and prevent IFN-a/h induction and DC maturation, requires both regulated dsRNA levels and the presence of viral N pro .
Introduction
Classical swine fever virus (CSFV) is an enveloped positivesense RNA virus that belongs to the genus Pestivirus within the Flaviviridae family (Fauquet et al., 2005) . The virus is highly contagious for pigs and wild boar and has a worldwide distribution. Depending on the CSFV strain, the outcome of an infection can vary from severe hemorrhagic symptoms with high mortality rate to a mild and almost unapparent disease. The other members of the Pestivirus genus are the bovine viral diarrhea virus (BVDV) and the border disease virus (BDV) that cause disease in cattle and sheep, respectively. Pestiviruses are closely related to the flaviviruses and hepaciviruses, two important groups of human pathogens of the Flaviviridae family (Fauquet et al., 2005) . The genome of the pestiviruses consists of a single RNA molecule of positive polarity. It contains one open reading frame (ORF) flanked by two nontranslated regions (NTR). An internal ribosome entry site (IRES) located in the 5V NTR mediates cap-independent translation initiation of a polyprotein. Co-and post-translational processing by cellular and viral proteases leads to the proteins N pro , C, E rns , E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B (for review, see Lindenbach and Rice, 2001) . N pro is unique to pestiviruses within the Flaviviridae and exhibits autoprotease activity resulting in rapid cleavage from the nascent polyprotein (Rumenapf et al., 1998; Stark et al., 1993; Wiskerchen et al., 1991) . So far, N pro is the only gene known to be non-essential for the pestivirus life cycle (Lai et al., 2000; Tratschin et al., 1998) . While mutant CSFV lacking the N pro gene (DN pro CSFV) are replication-competent in cell culture, they have lost their capacity to interfere with cellular antiviral defense mechanisms, i.e. double-stranded (ds) RNAmediated apoptosis and interferon (IFN)-a/h induction (Ruggli et al., 2003) . In fact, DN pro CSFV, unlike wild-type virus, induce IFN-a/h in macrophages and PK-15 cells (Ruggli et al., 2003) . DN pro CSFV are also avirulent in pigs but can induce a protective immune response (Mayer et al., 2004) . N pro of CSFV is an antagonist of dsRNA-mediated IFN-a/h induction independently of the CSFV context (La Rocca et al., 2005; Ruggli et al., in press) . A recent report suggests that N pro of BVDV is also involved in suppressing interferon-dependent antiviral responses (Horscroft et al., 2005) .
CSFV is a monocytotropic virus that replicates in dendritic cells (DC) without inducing cell activation (Carrasco et al., 2004) . This is important considering that DC are central players in the induction of early immune responses against pathogens. One process employed by DC is activation triggered by pathogen associated molecular patterns (PAMP). For RNA viruses, an important PAMP inducing host response is the dsRNA of replicative intermediates and replicative forms produced during genome replication (for review, see Goodbourn et al., 2000; Jacobs and Langland, 1996) . Such dsRNA is recognized in the cell by receptors such as toll-like receptor (TLR)3 (Alexopoulou et al., 2001; Matsumoto et al., 2004) , the retinoic acid inducible gene I (RIG-I) product (Yoneyama et al., 2004) , the melanoma differentiation-associated gene 5 (mda-5) product (Andrejeva et al., 2004; Kang et al., 2002) , the dsRNA-dependent protein kinase (PKR) and by the coupled 2V-5V oligoadenylate synthetase (2-5 OAS)/RNaseL system (Gil and Esteban, 2000; Player and Torrence, 1998) .
Although CSFV is generally noncytopathogenic (ncp) in cell culture and in DC, cytopathogenic (cp) biotypes have been isolated from infected animals (Aoki et al., 2001; Kosmidou et al., 1998; Meyers and Thiel, 1995) or arose spontaneously after multiple passages in cell culture (Meyers and Thiel, 1995; Mittelholzer et al., 1997) . With few exceptions (Aoki et al., 2004; Gallei et al., 2005; Hulst et al., 1998) , the cytopathic effect (cpe) observed so far with cp CSFV correlated with the presence of defective interfering particles (DI) associated with the wild-type helper virus. This DI consists of the 5V NTR, the codon for methionine, the genes NS3 to NS5B and the 3V NTR. The CSFV DI was shown to function as cp replicon independently of the helper virus, establishing that the genes N pro to NS2 were non-essential for pestivirus RNA replication in cell culture (Behrens et al., 1998; Moser et al., 1999; Tautz et al., 1999) . In addition, cp CSFV could be rescued in cell culture by transfection of ncp CSFV-infected cells with DI RNA or by co-transfection of in vitro transcripts of the cp replicon and the helper virus (Moser et al., 1999) . For CSFV, the significance of the cp biotype in pathogenesis is probably minor (Aoki et al., 2003; Kosmidou et al., 1998) , in contrast to BVDV for which the cp biotypes are associated with mucosal disease (Kummerer et al., 2000; Tautz et al., 1998 ). An interesting observation is that cp pestiviruses produce a significantly higher amount of total viral RNA compared with the corresponding ncp biotype (Kupfermann et al., 1996; Lackner et al., 2004; Mendez et al., 1998; Mittelholzer et al., 1997; Vassilev and Donis, 2000) . However, the double-stranded form of the viral RNA has never been specifically analyzed.
The present study aimed to characterize the role of viral dsRNA and N pro in CSFV-mediated innate immune activation in vitro. Induction of IFN-a/h was analyzed by comparing the IFN-a/h-competent PK-15 cell line with the SK-6 cell line that cannot be stimulated to produce IFN-a/h (Ruggli et al., 2003) . Porcine monocyte-derived DC were employed to analyze the role of viral dsRNA and N pro in DC activation and maturation. Both ncp and cp CSFV biotypes were used as models of low and high dsRNA-producing viruses, and the role played by N pro was tested with DN pro mutants of ncp and cp CSFV.
Results
Cp CSFV produces higher amounts of dsRNA than ncp CSFV Viral dsRNA is a well-known trigger of innate immune activation. Previous studies demonstrated that cp pestiviruses produced higher amounts of total viral RNA when compared to the corresponding ncp pestivirus. However, the double-stranded fraction of RNA occurring during replication of ncp and cp CSFV has never been identified and quantified so far. Therefore, we analyzed dsRNA in CSFV-infected cells by using the monoclonal antibody (mAb) J2. Detection of dsRNA in CSFV-infected SK-6 cells by immunofluorescence provided first evidence that cp CSFV produced more dsRNA than its ncp parent (Fig. 1A) . While the ncp CSFV-infected cells exhibited faint dsRNA dots (Fig. 1A, panel 4) , the cp CSFV-infected cells contained a high density of large bright fluorescent spots (Fig.  1A, panel 6) . Immunostaining of the viral glycoprotein E2 resulted in a comparable signal for both ncp and cp CSFV (Fig.  1A , panels 3 and 5). The specificity of the mAb J2 for CSFV dsRNA was assessed in a dot blot assay using in vitro synthesized nucleic acids. For this purpose, serial dilutions of plasmid DNA encoding the full-length genome (pA187-1) and of in vitro transcribed CSFV single-stranded (ss)RNA and dsRNA were dot-blotted onto a nitrocellulose membrane and subjected to immunodetection as described. With identical amounts of nucleic acids, a 400-fold stronger signal was detected for CSFV dsRNA than for CSFV ssRNA, whereas plasmid DNA was barely detectable even at the highest concentration (Fig. 1B) . The standard curve obtained with serial dilutions of in vitro synthesized CSFV dsRNA was then used to quantify dsRNA in extracts from mock, ncp and cp CSFVinfected SK-6 cells. Nucleic acid extracts were serially diluted and dot-blotted onto a nitrocellulose membrane (Fig. 1C) . Quantification revealed a 5-to 10-fold higher amount of dsRNA synthesized in cp CSFV-infected cells when compared to the ncp CSFV. This represents the first demonstration that cp CSFV produces higher levels of dsRNA than ncp CSFV, which may result in differential activation of the innate immune response.
The amount of dsRNA produced by cp CSFV is dependent on the cell type
We showed previously that the porcine cell lines SK-6 and PK-15 display a different response to stimulation by dsRNA (Ruggli et al., 2003, in press ). Therefore, we analyzed dsRNA in these two cell lines in comparison with primary porcine monocyte-derived DC. For this purpose, flow cytometry (FCM) was evaluated as an alternative to the dot blot assay for the quantification of dsRNA levels produced upon CSFV infection. First, SK-6 cells were either mock-infected or infected with ncp or cp CSFV and monitored for dsRNA levels by FCM. The difference of dsRNA fluorescence intensity between ncp and cp CSFV was comparable to that observed with the dot blot assay ( Fig. 2A) . Therefore, all following analyses were carried out by FCM. When SK-6 cells, PK-15 cells and DC were compared, the differences in dsRNA levels between ncp and cp CSFV varied considerably. In SK-6 cells that do not produce IFN-a/h, infection with cp CSFV resulted in the highest dsRNA production. In PK-15 cells, which are capable of producing IFN-h, the amount of viral dsRNA was lower compared to SK-6 cells. In DC, the difference in dsRNA synthesis between ncp and cp CSFV was the smallest (Fig. 2A) . A statistical analysis of the geometric mean fluorescence intensity (MFI) of two independent experiments using ANOVA revealed a significant difference for the dsRNA levels between mock-treated cells and cells infected with either ncp or cp CSFV for all the cell types (P < 0.004). The difference between ncp and cp CSFV was also significant in SK-6 and PK-15 cells (P < 0.004) and in DC ( P < 0.005) (Fig. 2B) . Interestingly, the cpe caused by cp CSFV was strong in SK-6 cells, less pronounced in PK-15 cells (Fig.  2C ) and absent in DC (data not shown). The cpe appeared in both SK-6 and PK-15 cells 16 h post-infection (p.i.) and resulted in complete lysis of the SK-6 monolayer 40 h p.i., whereas the PK-15 cells recovered (data not shown). No evidence of cell death could be detected in DC at any time (data not shown), despite virus replication detected by NS3 expression (Fig. 2C) . Taken together, these observations show celldependent differences in the control of virus replication and of viral dsRNA levels.
Cp CSFV induces IFN-a/b in PK-15 cells but not in DC
As dsRNA is known to induce synthesis of IFN-a/h, we asked whether the level of dsRNA was related to the degree of IFN-a/h induction. These experiments were performed with PK-15 and DC cultures since it was observed previously that no IFN-a/h could be induced in SK-6 cells (Ruggli et al., 2003) . Supernatants of cells infected with cp CSFV, ncp CSFV and mock were tested for bioactive IFN-a/h after virus neutralization, using the MxCAT reporter gene assay (Fig. 3) . i., cells were fixed and analyzed by confocal microscopy using the E2-specific mAb HC/TC26 (1, 3, 5) or the dsRNA-specific mAb J2 (2, 4, 6). The cytoskeleton was detected with fluorescent-conjugated phalloidin. (B) The specificity of the mAb J2 for dsRNA was tested in a dot blot assay. 10-fold serial dilutions of dsRNA, ssRNA and plasmid DNA were dot-blotted onto a nitrocellulose membrane. Detection was performed according to Materials and methods. (C) dsRNA from mock-, ncp CSFV-or cp CSFV-infected SK-6 cells was quantified in a dot blot assay. Nucleic acid extracts obtained 16 h p.i. were diluted as indicated and blotted onto a nitrocellulose membrane. dsRNA was detected according to Materials and methods and quantified by comparison with a standard curve based on in vitro synthesized dsRNA. Amounts of dsRNA are indicated in nanograms for each dot.
In accordance with previous data (Carrasco et al., 2004; Ruggli et al., 2003) , ncp CSFV did not induce any detectable IFN-a/h, neither in PK-15 cells nor in DC. In PK-15 cells, cp CSFV induced IFN-a/h in a non-linear, multiplicity of infection (m.o.i.)-dependent manner. Interestingly, the infection of DC with cp CSFV did not induce any detectable interferon synthesis, which may relate to the only slight increase of dsRNA when compared with ncp CSFV (see Fig. 2 ).
Cp CSFV induces DC maturation
Next, we investigated the maturation level of ncp and cp CSFV-infected DC in order to determine whether these cells respond differently to the two biotypes. For this purpose, the level of CD80/86 and MHC II molecules on the cell surface was monitored by FCM. Cells infected with cp CSFV expressed higher levels of MHC II and CD80/86 molecules (Fig. 4A ). The differences of the geometrical MFI values analyzed using ANOVA were statistically significant (P < 0.004 for CD80/86, P < 0.03 for MHC II). The infection with ncp CSFV did not result in a statistically significant upregulation of MHC II and CD80/86 when compared to mock, although the raw data indicated a slight increase of the expression levels. In conclusion, while viral protein expression in DC did not differ between cp and ncp CSFV as measured by the levels of N pro and NS3 ( Fig. 4B ), cp CSFV induced maturation of DC without detectable IFN-a/h production.
Maturation of DC and IFN-a/b secretion can be triggered by in vitro synthesized CSFV dsRNA
Since we demonstrated activation of DC by cp CSFV with a small increase of dsRNA levels and without detectable IFN-a/h secretion, the next experiments were aimed at determining the activation potential of in vitro synthesized CSFV dsRNA. CSFV dsRNA obtained in vitro was not replication-competent (data not shown) and was compared with in vitro transcribed non-replicating CSFV ssRNA and with plasmid DNA carrying the full-length CSFV genome sequence as control. DC were lipofected with CSFV DNA, ssRNA or dsRNA and monitored by FCM for CD80/86 and MHC II upregulation. Transfection of DC with dsRNA resulted in a significant increase in MHC II levels (P < 0.005) (Fig. 4C) . CD80/86 expression levels were not increased with dsRNA and only slightly increased with plasmid DNA (Fig. 4C) . The survival rate of DC after lipofection of dsRNA was reduced when compared to transfection with plasmid DNA and with ssRNA (data not shown). Interestingly, transfection of DC with synthetic CSFV dsRNA resulted in secretion of IFN-a/h (Fig. 4D) , in contrast to the infection with cp CSFV (Fig. 3) . The induction was specific for dsRNA and was not due to the transfection process since ssRNA and plasmid DNA did not induce IFN-a/h secretion.
DN
pro CSFV induces IFN-a/b secretion and DC maturation Similar to cp CSFV in PK-15 cells (Fig. 3) , DN pro CSFV is an inducer of IFN-a/h in these cells and in macrophages (Ruggli et al., 2003) . The fact that DN pro CSFV is ncp suggests that there is no direct link between cytopathogenicity and IFNa/h induction. To elaborate on this, we analyzed IFN-a/h secreted by DC in response to infection with DN pro CSFV and monitored CD80/86 and MHC class II expression. DC produced IFN-a/h in response to infection with DN pro CSFV (Fig. 5A ) in absence of any detectable cpe. Furthermore, DN pro CSFV induced an upregulation of CD80/86 and of MHC class II molecules on DC (Fig. 5B) . The difference in the CD80/86 upregulation between DN pro CSFV and ncp CSFV analyzed using ANOVA was statistically significant ( P < 0.008). The increased activation in absence of N pro occurred despite slight reduced levels of viral protein expression as measured by NS3 (Fig. 5C ). This confirms that cytopathogenicity of CSFV is not a prerequisite for DC activation and suggests that N pro is required for the prevention of such activation.
pro CSFV-and ncp CSFV-infected cells produce comparable amounts of dsRNA We have shown above that IFN-a/h induction in PK-15 cells and activation of DC correlated with increased levels of dsRNA observed with cp CSFV but that cytopathogenicity was not a prerequisite for DC activation. Since DN pro CSFV induced IFN-a/h and activated DC without being cytopathogenic, we analyzed whether N pro was involved in the regulation of dsRNA levels during virus infection. For this purpose, we quantified dsRNA induced by DN pro CSFV in comparison with ncp CSFV in the three different cell types. There was no statistical difference in the amounts of dsRNA between ncp and DN pro CSFV in SK-6 and PK-15 cells (Figs. 6A and 6B) . In DC infected with DN pro CSFV, one population of cells displayed a dsRNA-dependent fluorescence intensity comparable with ncp CSFV-infected cells, and a second population of cells showed a decreased dsRNA fluorescence at the level of non-infected cells (Fig. 6A ). This could be explained by the fact that the replication of DN pro CSFV was impaired in DC when compared with ncp CSFV. At the same m.o.i., only 40% of the DC infected with DN pro CSFV expressed NS3, whereas with ncp CSFV approximately 90% of the cells were NS3 positive at the same time after infection (Fig. 6C) . From these experiments, we conclude that IFN-a/h induction in PK-15 cells and activation of DC by DN pro CSFV are not due to increased dsRNA accumulation. (Fig. 7A) . When IFN-a/h bioactivity was measured, cp DN pro CSFV infection resulted in a 1.5-to 5-fold increase in IFN-a/h synthesis in PK-15 cells and in DC respectively, when compared with cp CSFV (Fig. 7B) . This was particularly remarkable with DC, in which cp DN pro CSFV replication was not detectable when measured by NS3 expression (Fig. 7A) . Analysis of DC activation did not reveal any significant difference in the levels of CD80/86 with either virus tested (Fig. 7C) . However, for cp DN pro CSFV, expression of MHC II molecules was increased by two-fold when compared to either cp CSFV or DN pro CSFV (Fig. 7C) . Taken together, these experiments show that increased amounts of dsRNA , the asterisk represents a statistical significant upregulation of CD80/86 (P < 0.002, n = 6) and of MHC II (P < 0.035, n = 6). In panel (C), the upregulation of MHC II expression in DC transfected with dsRNA was statistically significant as shown by the asterisk (P < 0.005, n = 3) when compared with mock, DNA and ssRNA. For all the graphs, mean values are depicted. The error bars represent the 95% confidence interval. and the lack of N pro synergistically contribute to the activation of DC and IFN-a/h induction.
Discussion
For immunological sensing of virus infections, DC play a major role through PAMP receptors such as the TLRs. The development of memory responses against antigen has been demonstrated to depend on TLR stimulation (Iwasaki and Medzhitov, 2004) . Many viruses have successfully evolved mechanisms to evade detection by the immune system, including the capacity to prevent immune activation and permit their replication in IFN-a/h-competent cells (for selected reviews, see Basler and Garcia-Sastre, 2002; Goodbourn et al., 2000; Tortorella et al., 2000; Weber et al., 2004) . Recently, we showed that CSFV has the capacity to replicate in DC without inducing their activation (Carrasco et al., 2004) . In order to further elaborate on this observation, the present study analyzed the interaction of CSFV with monocyte-derived DC. Of particular interest were the dsRNA intermediates formed by RNA viruses during their replication, clear candidates to trigger IFN-a/h production (for review, see Goodbourn et al., 2000; Jacobs and Langland, 1996) . In this same vein, it is known that cp pestiviruses induce higher RNA levels than their ncp counterparts (Kupfermann et al., 1996; Lackner et al., 2004; Mendez et al., 1998; Mittelholzer et al., 1997; Vassilev and Donis, 2000) , but it was not known whether this is also true for the double-stranded forms of the RNA.
The present work demonstrates that cp CSFV produces elevated amounts of dsRNA, compared with the ncp biotype, but with variations dependent on the cell type infected. SK-6 cells accumulated more dsRNA than PK-15 cells and DC. In fact, the latter showed only a minor difference in dsRNA levels between the cp and ncp biotypes. With the PK-15 cells, this might be reflecting the induction of IFN-a/h by the cp CSFV. In DC, although there was no IFN-a/h detectable in the supernatant, the increased expression of CD80/86 and MHC class II after cp CSFV infection demonstrated DC activation, suggesting that also in these cells an antiviral state controlling dsRNA accumulation would be induced. Interestingly, cytopathogenicity was observed only in cell cultures where high amounts of dsRNA were produced, the cp CSFV being cytopathic for SK-6 and PK-15 cells, but not for DC. Similar results have been reported in terms of cp BVDV being noncytopathogenic in bovine DC (Glew et al., 2003) , although these were induced to produce IFN-a/h. Honda et al. demonstrated that IFN-a/h signaling is required for dsRNA-induced DC maturation in vitro (Honda et al., 2003) . This would appear to be in contradiction with the observation that cp CSFV upregulates CD80/86 and MHC II molecules without detectable IFN-a/h bioactivity. Nevertheless, low levels of IFN-a/h would quickly become assimilated by the DC and thus be undetectable. Certainly, dsRNA can induce IFN-a/h in DC as we demonstrate that in vitro synthesized CSFV-derived dsRNA transfected into DC induced IFN-a/h. Along this line is our recent report that the activation of DC by transfected synthetic mRNA molecules was dependent on secondary dsRNA structures (Ceppi et al., 2005) . Furthermore, a recent study demonstrated that the addition of cationic lipids prolongates the retention time of nucleic acids in the endosomal compartment in DC and thus enhances the IFN response (Honda et al., 2005) .
DC activation by dsRNA can be mediated via TLR3 (for review, see Matsumoto et al., 2004) , but, with RNA virus infections, it is necessary to consider TLR7 and TLR8 as receptors for ssRNA (Barchet et al., 2005; Diebold et al., 2004; Heil et al., 2004; Lund et al., 2004) . However, the monocyte-derived DC used in the present study do not respond to in vitro synthesized CSFV ssRNA, supporting that CSFV dsRNA is the main trigger for myeloid DC activation observed with cp CSFV. Human monocyte-derived DC also lack responsiveness to ssRNA, in contrast to plasmacytoid DC (reviewed in Liu, 2005) .
Having identified the importance of dsRNA in triggering myeloid DC, the question remained concerning the role of the viral N pro . Previous work has shown N pro to be important for counteracting cellular antiviral responses such as IFN-a/h secretion (Horscroft et al., 2005; La Rocca et al., 2005; Ruggli et al., 2003, in press) . Although the absence of N pro did not impair viral replication in SK-6 cells, DN pro CSFV was incapable of efficient replication in DC. These mutants induced IFN-a/h production by the DC, which would explain the limitation of the virus replication, similar to that reported with infected macrophages and PK-15 cells (Ruggli et al., 2003) . Horscroft and co-workers also reported that BVDV replicons lacking the N pro gene failed to establish stable replication in Huh-7 cells (Horscroft et al., 2005) . It is still unclear if this antiviral state is due to IFN-a/h activity. What is known is that CSFV replication in DC is impaired by IFN-a treatment (data not shown).
Recently, Lackner and co-workers showed that the temporal modulation of NS2 -3 processing by the NS2 autoprotease is crucial in RNA replication control and that the intracellular level of NS3 strictly correlates with the efficiency of RNA replication (Lackner et al., 2004) . Whether these proteins regulate the dsRNA levels remains to be established. Although N pro can be implicated in controlling IFN-a/h induction, our results show that N pro is not regulating the dsRNA turnover. It is more likely that N pro is inhibiting the cellular response to dsRNA. Using a virus engineered to combine elevated dsRNA The MFI obtained in two independent experiments (n = 6) was submitted to statistical analysis using ANOVA on ranks. The P values obtained for the differences between each group are indicated. (C) At the time of dsRNA detection, parallel cultures of SK-6 and PK-15 cells were subjected to immunoperoxidase staining for viral NS3. For DC, analysis of NS3 expression was performed by FCM. levels in absence of N pro (cp DN pro CSFV), an additive effect on IFN-a/h induction and DC activation was observed.
The present work has given rise to a model of CSFV -host interaction governing virus evasion of host cell responses. Regulation of CSFV RNA turnover with minimal accumulation of dsRNA on one hand and N pro as a viral inhibitor of innate immune activation on the other hand are key elements. They account for a successful initiation of virus replication in the primary target cells (monocytic cells), allowing dissemination in the host. This is a particularly critical event for a virus targeting cells of the immune system, especially highly endocytic cells such as macrophages and dendritic cells. By such means, CSFV not only replicates in IFN-producing cells, but also controls IFN induction and DC maturation. Another viral protein -E rns -may well be involved due to its proposed control of dsRNA-mediated induction of IFN-h (Iqbal et al., 2004) . Further studies are required to understand how the dsRNA turnover is regulated and what mechanisms are involved in N pro -induced control of innate immune activation. Such a detailed characterization will permit the understanding of the early phases of CSFV pathogenesis.
Materials and methods

Cells
The swine kidney cell line SK-6 (Kasza et al., 1972) was propagated in Earl's minimal essential medium containing 7% horse serum (GibcoBRL). The porcine kidney cell line PK-15 (American Type Culture Collection, Manassas, VA, USA) was maintained in Dulbecco's modified eagle medium (DMEM) supplemented with non-essential amino acids, 1 mM NaPyruvat and 5% horse serum (GibcoBRL). Porcine DC were prepared as described elsewhere (Carrasco et al., 2001) . Briefly, peripheral blood mononuclear cells were isolated from specific pathogen-free pigs bred at our institute. SWC3 positive monocytes were sorted using the MACS system (Miltenyi Biotec) and differentiated to DC by incubation for 4 days at 39 -C in DMEM with 10% porcine serum (Sigma) in the presence of 100 U/ml recombinant porcine IL-4 and 150 ng/ml recombinant porcine GM-CSF (kindly provided by Dr. Shigeki Inumaru, Institute for Animal Health, Ibaraki, Japan). The IL-4 was prepared in our laboratory as described previously (Carrasco et al., 2001 ).
Viruses
The viruses vA187-1 and vA187-DN pro were rescued by electroporation of SK-6 cells with in vitro transcribed RNA from the plasmid cDNA clones pA187-1 (Ruggli et al., 1996) and pA187-DN pro (Ruggli et al., 2003) as previously described (Moser et al., 1999) . Cp CSFV was obtained by co-transfection of SK-6 cells with in vitro transcribed RNA from plasmids pA187-1 and pA187-D4764iv (Moser et al., 1999 ) at a ratio of 1:4. For the recovery of cp DN pro CSFV, SK-6 cells were cotransfected with in vitro transcribed RNA from plasmids pA187-DN pro and pA187-D4764iv at a ratio of 1:10. All the virus titers were determined on SK-6 cells by standard endpoint dilution technique and were expressed as 50% tissue culture infectious doses (TCID 50 )/ml. The m.o.i. used with SK-6 and PK-15 cells was calculated from the titer obtained with the respective cell line. Titration on DC was not performed, and the m.o.i. was calculated based on the SK-6 titer.
In vitro synthesis of CSFV dsRNA CSFV dsRNA was obtained by annealing of in vitro transcribed full-length positive and negative-sense viral RNA. For this purpose, plasmid pA187-1 was modified to allow in vitro run-off transcription of negative-sense CSFV RNA. A phosphorylated DNA cassette obtained by annealing of primers T7-XhoI-L (5V-TATAGTGAGTCGTATTAC) and T7-XhoI-R (5V-TCGAGTAATACGACTCACTATA) was ligated between the SrfI and XhoI sites of pA187-1, resulting in plasmid pA187-2xT7. Then, the SalI to ClaI fragment of plasmid pA187-2xT7 containing the 5V-terminal T7 promoter and the 5V end of the genome was replaced by the SalI to ClaI fragment of plasmid pA187T3-SnaBI (Moser C., unpublished) containing a unique SnaBI restriction site for linearization at the precise 5V end of the genome. The new plasmid was called pA187-5V-SnaBI. In vitro transcription of RNA was performed with the MEGAscript T7 kit (Ambion) as described elsewhere (Moser et al., 1999) . Full-length run-off transcripts were synthesized in independent reactions from SrfI-linearized plasmid pA187-1 for positive-sense RNA and from SnaBIlinearized plasmid pA187-5V-SnaBI for negative-sense RNA. Subsequently, equimolar amounts of both RNA strands were mixed and denatured at 75 -C for 5 min prior to annealing at room temperature to obtain CSFV dsRNA. The integrity of the dsRNA was confirmed by digestion experiments with RNase A1 and T in 10 mM Tris -HCl pH 7.5, 300 mM NaCl and 5 mM EDTA. A non-replicating ssRNA control transcript was synthesized from a pA187-1-derived construct carrying mutations in the NS5B gene resulting in a Gly -Asp -Asp to AlaAla -Ala substitution at amino acid positions 3627 to 3629 of the polyprotein (details of the construction can be obtained on request).
Transfection of DC
DC were transfected as previously described (Ceppi et al., 2005) . Briefly, cells were harvested after 4 days of culture and washed twice with Opti-MEM (GibcoBRL). Nucleic acids were diluted in Opti-MEM, and Transfast lipofection agent (Invitrogen) was added at a ratio of 3 Al Transfast per 1 Ag nucleic acid. The mixture was incubated at room temperature for 15 min prior to addition to the cells. 4 Ag of nucleic acids was transfected per 10 6 cells. The lipofection mix was incubated with the cell suspension at 39 -C for 1 h. The cells were then washed twice in culture medium supplemented with recombinant porcine GM-CSF/IL4 (concentrations as indicated above) and plated in 6-well plates. Two days post-transfection, the cells were harvested and acquired by FCM for CD80/86 and MHC class II expression. Supernatants were subjected to analysis of IFN-a/h bioactivity. Lipofection efficacy was monitored with an mRNA encoding EGFP (Ceppi et al., 2005) .
Antibodies and cytokines
Monoclonal antibodies directed against the viral protein NS3 (C16) (Greiser-Wilke et al., 1992) and the E2 glycoprotein (HC/TC26) (Greiser-Wilke et al., 1990) (kindly provided by Dr. Irene Greiser-Wilke, Hannover Veterinary School, Hannover, Germany) were used for virus detection by FCM and immunohistochemistry. For the detection of viral proteins by Western blotting, polyclonal rabbit sera against N pro (Ruggli et al., in press) and NS3 (Ruggli N., unpublished) were utilized. dsRNA was visualized with the dsRNA-specific mAb J2 (English and Scientific Consulting Bt., Szirak, Hungary) described to detect the A-helix of double-stranded polyribonucleotide complexes larger than 11 base pairs (Schonborn et al., 1991) . Secondary rabbit anti-mouse biotinylated antibody (DAKO) was used in combination with IR Dye-labeled streptavidin (Rockland). The level of CD80/86 molecules expressed on the cell surface was measured using human CTLA4 coupled to murine immunoglobulin (Ancell). MHC II levels were determined with mAb MSA3 (Hammerberg and Schurig, 1986) . Recombinant porcine IFN-a was produced in HEK293EBNA cells as described elsewhere (Balmelli et al., 2005) . Porcine tumor necrosis factor a (TNF) was prepared from L929 cells expressing porcine TNF, kindly provided by Dr. Giuseppe Bertoni, Vetsuisse Faculty, University of Berne, Switzerland (Von Niederhausern et al., 1993) .
Immunostaining and confocal microscopy SK-6 cells were cultured and infected with CSFV in eightwell culture slides (Becton Dickinson). Prior to immunostaining, the cells were washed with PBS, fixed with 4% (w/v) paraformaldehyde for 15 min and washed again with PBS. The cells were then incubated for 20 min at 4 -C with the respective monoclonal antibody diluted in PBS/0.3% (w/v) saponin (Sigma) and washed again three times with PBS containing 0.1% (w/v) saponin. Detection was performed with Alexa-488 fluorochrome-labeled anti-mouse secondary antibody (Molecular Probes). The cytoskeleton was stained with Alexa-546-conjugated phalloidin (Molecular Probes). Analysis was performed with a Leica TCS-SL spectral confocal microscope and Leica LCS software (Leica).
dsRNA dot blot
A dot blot assay was established for the quantification of dsRNA extracted from CSFV-infected cells. Eight million cells were harvested 16 h p.i. and washed twice with PBS. The cells were resuspended in 900 Al lysis buffer (200 mM NaCl, 100 mM Tris -HCl pH 8, 2% sodium dodecyl sulfate and 2% hmercaptoethanol). Nucleic acids were extracted and purified from the lysate with phenol:chloroform:isoamylalcohol (25:24:1) and precipitated with isopropanol. The pellet was washed with 70% ethanol, dried and resuspended in water. Serial dilutions of the extracts were dot-blotted with a Minifold II dot blot device (Schleicher & Schuell) onto a Protran nitrocellulose membrane (Schleicher & Schuell) . Nucleic acids were fixed by baking the membrane at 80 -C for 1 h. The membrane was then blocked for 1 h at room temperature in a blocking solution consisting of Odyssey Blocking Buffer (LI-COR) diluted 1:1 with PBS (80 mM Na 2 HPO 4 , 20 mM NaH 2 PO 4 , 100 mM NaCl, pH 7.3). The primary antibody J2 was diluted to a concentration of 0.5 Ag/ml (1:2000) in the blocking solution. The secondary biotinylated rabbit F(abV) 2 anti-mouse IgG (DAKO) and the IR Dye-labeled streptavidin were diluted 1:2000 and 1:2500 respectively in the blocking solution containing 0.1% Tween 20. Between incubation steps, the membrane was washed 4 times for 5 min each with PBS supplemented with 0.1% Tween 20. Two wash steps with PBS lacking detergent were carried out prior to image acquisition and quantification using the Odyssey Infrared Imaging System (LI-COR). Quantification of the nucleic acids was based on a standard curve obtained with in vitro synthesized CSFV dsRNA.
Western blotting
DC were lysed 48 h p.i. with a hypotonic buffer (20 mM morpholinepropanesulfonic acid, 10 mM NaCl, 1.5 mM MgCl 2 , 1% Triton X-100, pH 6.5). Viral proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed by Western blotting as previously described (Ruggli et al., in press ).
Flow cytometry
FCM was performed as described elsewhere (Summerfield and McCullough, 1997) . For staining of cell surface molecules, unfixed cells were incubated for 15 min on ice with the respective primary and secondary antibodies diluted in CellWash (Becton Dickinson). After each antibody incubation, cells were washed once with CellWash. For the detection of the intracellular antigens NS3 and dsRNA, cells were fixed and permeabilized using a cell fixation and permeabilization kit (Harlan Sera-Lab Ltd). The primary mAb C16 and J2 respectively were diluted in the permeabilization agent. mAb J2 was used at a working concentration of 10 Ag/ml (1:100 dilution). The acquisition was done by FCM (FACSCalibur, Becton Dickinson).
Measurement of IFN-a/b bioactivity
Bioactive IFN-a/h in cell culture supernatant was measured by using an Mx/CAT reporter gene assay initially developed for the quantification of bovine IFN-a/h (Fray et al., 2001 ). This assay was validated for porcine IFN-a/h and was performed as previously described (Ruggli et al., 2003) . Infectious CSFV present in the samples to be analyzed was neutralized by incubation for 1 h at 4 -C with polyclonal pig anti-CSFV serum 600-88 (Ruggli et al., 1995) diluted 1:100. RNA was removed by treating the samples for 1 h at 37 -C with a cocktail of 5 U/ ml RNaseA and 200 U/ml RNase T1 (Ambion).
Statistical analysis
Statistical and graphical analyses were carried out with the SigmaStat and SigmaPlot software package (SPSS). If applicable, parametric analysis of variance (ANOVA) combined with the Student's t test was used. If the samples of the populations did not satisfy the normal distribution or the equal variance conditions, ANOVA on ranks combined with a rank sum test was used. The P values were adjusted with Bonferroni correction.
